Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2013/057208external-prioritypatent/WO2014161595A1/en
Priority claimed from PCT/EP2013/057205external-prioritypatent/WO2014161594A1/en
Application filed by Polichem SafiledCriticalPolichem Sa
Publication of UY35525ApublicationCriticalpatent/UY35525A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
La presente invención está dirigida a formulaciones administrables por vía oral o rectal que contienen pidotimod, o una sal fisiológicamente aceptabl e del mismo, junto con al menos un excipiente farmacéuticamente aceptable. Dichas formulaciones est án principalmente dirigidas al tratamiento de síndrome de intestino irritable o enfermedad inflamat oria intestinal.The present invention is directed to orally or rectally administrable formulations containing pidotimod, or a physiologically acceptable salt thereof, together with at least one pharmaceutically acceptable excipient. Such formulations are primarily aimed at the treatment of irritable bowel syndrome or inflammatory bowel disease.
UY0001035525A2013-04-052014-04-04
ADMINISTRABLE FORMULATIONS BY ORAL OR RECTAL ROUTES CONTAINING PIDOTIMOD
UY35525A
(en)
APPLICATION OF DECAMETOXIN AS A PHARMACEUTICALLY ACTIVE SUBSTANCE FOR THE TREATMENT OF DISEASES OF THE GASTROINTESTINAL TRACT AND INTESTINAL INFECTIONS OF ORAL